Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.
Our latest market snapshot offers an introduction to the real world patient data collected by our Therapy Watch HCV study, providing you with an overview of HCV patient profiles and treatment pathways.
Find out more:
http://www.researchpartnership.com/-rapport/2016/02/infographic-hcv-eu/?utm_source=Research%20Partne...